Fighting Covid-19， Hepalink in Action
The Covid-19 epidemic touches the heart of all Chinese people. Faced with the raging epidemic, Hepalink, as a pharmaceutical enterprise, takes on its social responsibilities through practical actions. On February 2, 2020, the company launched emergence donations. The first enoxaparin sodium injections “Prolongin”, specifically used for Covid-19 patients, were delivered to Shenzhen Third People’s Hospital on the morning of February 3.
We hope that our products, along with our wisdom and love, can become a powerful weapon for our respectable and admirable front-line medical workers to save the life of patients. Here, we pay our respects to all front-line medical and anti-epidemic workers!